中国中药(00570)今日盘中大涨8.56%,引发市场高度关注。
消息面上,中国中药近期被国药集团重组并购,体现出国有资本运作的持续进行,这是推动其股价大涨的主要原因。根据新闻报导,过去10年间,国药集团不断进行重组整合,2021年曾收购太极集团,国改逻辑持续演绎。
此外,中国中药早前私有化计划因条件未获满足而告吹,之后股价持续走低,本次大涨可视为"私有化落空"后的反弹。中国中药作为中国医药集团现代中药业务的核心平台,在中医药行业占据重要地位,资本运作预期为其注入增长动能。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.